Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Psychosom Med. 2013 Dec 23;76(1):66–73. doi: 10.1097/PSY.0000000000000019

Table 2.

Clinical Characteristics of the Final Sample.

MDD (n=49) RMD (n=24) Control (n=45) Post Hoc Group
Comparisons
(ps<.05)
Antidepressants
Past Month		 18.4% 12.5% 0% MDD>CTRL
RMD>CTRL
BDI-II 31.33(9.63) 6.58(5.75) 2.80(4.37) MDD>RMD>CTRL
HDRS 17.96(4.79) 1.46(2.11) .84(1.24) MDD>CTRL
MDD>RMD
BAI 18.96(9.06) 7.04(8.31) 2.02(3.14) MDD>RMD>CTRL
PANAS-PA 23.45(6.30) 34.63(6.00) 34.33(6.97) MDD<CTRL
MDD<RMD
PANAS-NA 25.19(7.78) 15.83(5.17) 12.22(2.46) MDD>RMD>CTRL
BMI 28.45 (9.03) 26.49 (7.08) 24.65 (4.82) MDD>CTRL
MDD>RMD
PPAQ Total
Kcal/Day		 476.95(1194.23) 1197.67(1418.08) 1430.12(1946.6
2)		 MDD<CTRL
MDD<RMD
PSQI1 10.35(3.53) 6.09(3.02) 3.87(2.34) MDD>RMD>CTRL
1

Note: Higher scores on the PSQI indicate poorer sleep and scores of >5 are generally considered indicative of poor sleep quality.